REVBIO, INC.

Other Health CareMedical DeviceBiomaterialClinical Stage

📍 Lowell, MA, United States• Founded 2014

StreetZero Signal 69

Be the first to signal interest

About REVBIO, INC.

RevBio, Inc., is a clinical stage medical device company engaged in the development and commercialization of a patented, synthetic, injectable, self-setting, and osteoconductive bone adhesive biomaterial called TETRANITE®. The company has received multiple grants from NIH, NASA, and the Department of Defense totaling over $9 million, including a $2 million Phase II SBIR grant from NIDCR to advance its dental adhesive bone scaffold product into clinical development.

LATEST FUNDINGPrivate Placement

$15.0M

Announced 2026-10-02

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for REVBIO, INC..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES—

FOUNDED2014

HQLowell, MA, United States

Industry

Other Health Care

Investors

Pacific Dental Services

Key highlights

Awarded $2 million NIDCR SBIR Phase II grant for dental bone scaffold development
Secured over $17 million in non-dilutive SBIR grants from NIH and other agencies
Raised $5 million convertible note and received strategic investment from Pacific Dental Services in 2023
Achieved ISO 13485 certification for manufacturing and quality systems

Ask StreetZero about REVBIO, INC.

Put our AI to work on this deal.

What is REVBIO, INC.'s value proposition?Who are REVBIO, INC.'s competitors?Why does this raise matter?Summarize REVBIO, INC. for an investor.

Similar companies

Other Other Health Care deals, ranked by Signal.

Precision Neuroscience Corp

$250.0M

Edgewood OpCo, LLC

$87.0M

Click Therapeutics, Inc.

$50.0M

Alpfa Medical, Inc.

$80.3M

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.